Manganese
|
Mn-induced neuronal apoptosis via the activation of PKA or Ca2+/p38-MAPK/CREB signaling |
PC12 cells and mouse brain tissue |
Mice - 20 mg/kg |
Mice - Daily intraperitoneal injections for 60 days |
(Zhu et al., 2019) |
|
|
|
Mn-induced oxidative stress via increased LRRK2/p38- and ERK-MAPK signaling |
Human microglial cells |
MnCl2 - 250 μM |
24 hours |
(Kim et al., 2019) |
|
|
|
Mn-induced inflammation via p38-and ERK-MAPK/COX-2 signaling pathways |
Rat thalamus and hippocampus |
MnCl2·4H2O - 15 mg/kg |
12 weeks |
(Li et al., 2018) |
|
Cadmium
|
Cd-induced cell death via that Cd-Ca2+-p38/ERK-MAPK signaling pathway |
Cerebral cortical astrocytes |
10 μM CdCl2 (chronic exposure) |
12 hours (chronic exposure) |
(Jiang et al., 2015). |
|
|
|
100 or 300 μM CdCl2 (acute exposure) |
0.5–2 hours (acute exposure) |
|
|
|
|
Cd-induced apoptotic cell death via ROS-mediated increase in ERK1/2 and p38 signalling |
PC12 and primary neurons from mouse cerebral cortex |
10 μM and 20 μM CdCl2
|
24 hours |
(Xu et al., 2016) |
|
|
|
Cd-induced neuroinflammation via increased production of IL-6 and IL-8 ERK1/2 and p38 pathways |
U-87 MG cells |
10 μM CdCl2
|
3 hours |
(Kasemsuk et al., 2020) |
|
|
|
Neuroinflammation via γ-secretase/p38-MAPK/CREB-mediated increased COX-2 expression |
C6 astrocytes cells |
10 and 25 μM CdCl2
|
6 hours |
(Lim et al., 2019). |
|
Mercury
|
Neuronal loss via p38-MAPK/CREB/c-fos/BDNF upregulation. |
Mice |
30 ppm MeHg |
8 weeks |
(Fujimura and Usuki, 2017) |
|
|
|
Mercuric chloride-induced DNA fragmentation and cell death via elevated p38- and ERK-MAPK/Bax/caspase-3 signaling |
Rat |
5 mg/kg HgCl2
|
14 days |
(Fadda et al., 2020) |
|
|
|
Mercuric chloride-induced inflammation evident by an elevation in serum level of TNF-α and IL-6 via p38- and ERK-MAPK activation |
Rat |
5 mg/kg HgCl2
|
14 days |
(Fadda et al., 2020) |
|
Chlorpyrifos
|
Apoptotic cell death via increased caspase-3 mediated by p38- and ERK-MAPK signaling pathways |
PC12 cells |
100 and 200 μM |
24 hours |
(Lee et al., 2012) |
|
|
|
Cytotoxicity and neuronal death due to increased p-p38 and p-ERK expression and subsequently increased caspase-3 levels. |
SH-SY5Y cells |
100 μM |
24 hours |
(Ki et al., 2013) |
|
|
|
Elevated ROS production via increased p38- and ERK-MAPK/ NF-κB signaling |
SH-SY5Y cells |
50 – 200 μM |
24 hours |
(Lee et al., 2014) |
|
Soman
|
Increased p38-MAPK phosphorylation |
Cerebellar Purkinje cells |
60 μg/kg |
One dose |
(Pejchal et al., 2009). |
|
Perfluorooctane sulfonic acid
|
Increased TNF-α and IL-6 expression partly by increased ERK1/2-MAPK/ NF-κB |
BV2 microglial cells |
0.1–10 μM |
6 or 12 hours |
(Zhu et al., 2015) |
|
Tetrachloro-p-benzoquinone
|
p38, ERK, and JNK mediated increase of TNF-α, IL-1β and IL-6 |
Rat pheochromocytoma PC12 cells |
25 μM |
6 hours |
(Fu et al., 2017). |
|
Benzophenone-3
|
p38-MAPK-mediated apoptotic cell death. |
mouse neuronal cell (hippocampal and neocortical) culture |
25–100 μM |
6 or 24 hours |
(Wnuk et al., 2018) |
|
Triphenyl phosphate
|
p38-, ERK-, and JNK-MAPK/FoxO-mediated apoptotic cell death in the cortex, thalamus, and hippocampus. |
C57/BL6 mice |
50 or 100 mg/kg |
30 days |
(Liu et al., 2020) |